These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28753127)

  • 1. IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1.
    Dai N; Ji F; Wright J; Minichiello L; Sadreyev R; Avruch J
    Elife; 2017 Jul; 6():. PubMed ID: 28753127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry.
    Dai N; Rapley J; Angel M; Yanik MF; Blower MD; Avruch J
    Genes Dev; 2011 Jun; 25(11):1159-72. PubMed ID: 21576258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts.
    Dai N; Christiansen J; Nielsen FC; Avruch J
    Genes Dev; 2013 Feb; 27(3):301-12. PubMed ID: 23388827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.
    Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H
    Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMP2 Increases Mouse Skeletal Muscle Mass and Voluntary Activity by Enhancing Autocrine Insulin-Like Growth Factor 2 Production and Optimizing Muscle Metabolism.
    Regué L; Ji F; Flicker D; Kramer D; Pierce W; Davidoff T; Widrick JJ; Houstis N; Minichiello L; Dai N; Avruch J
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30692269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.
    Li Y; Francia G; Zhang JY
    Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression.
    Regué L; Zhao L; Ji F; Wang H; Avruch J; Dai N
    Mol Metab; 2021 Jun; 48():101209. PubMed ID: 33705986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
    Dahlem C; Barghash A; Puchas P; Haybaeck J; Kessler SM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma.
    Barghash A; Golob-Schwarzl N; Helms V; Haybaeck J; Kessler SM
    Oncotarget; 2016 Aug; 7(31):49743-49750. PubMed ID: 27391348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.
    Kessler SM; Pokorny J; Zimmer V; Laggai S; Lammert F; Bohle RM; Kiemer AK
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G328-36. PubMed ID: 23257922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.
    Gebeshuber CA; Martinez J
    Oncogene; 2013 Jul; 32(27):3306-10. PubMed ID: 22926517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury.
    Zhu X; Yan J; Bregere C; Zelmer A; Goerne T; Kapfhammer JP; Guzman R; Wellmann S
    Nat Commun; 2019 Sep; 10(1):3983. PubMed ID: 31484925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA IGF2-AS represses breast cancer tumorigenesis by epigenetically regulating IGF2.
    Zhang Y; Yan H; Jiang Y; Chen T; Ma Z; Li F; Lin M; Xu Y; Zhang X; Zhang J; He H
    Exp Biol Med (Maywood); 2021 Feb; 246(4):371-379. PubMed ID: 33175607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
    Moura DS; Mondaza-Hernandez JL; Sanchez-Bustos P; Peña-Chilet M; Cordero-Varela JA; Lopez-Alvarez M; Carrillo-Garcia J; Martin-Ruiz M; Romero-Gonzalez P; Renshaw-Calderon M; Ramos R; Marcilla D; Alvarez-Alegret R; Agra-Pujol C; Izquierdo F; Ortega-Medina L; Martin-Davila F; Hernandez-Leon CN; Romagosa C; Salgado MAV; Lavernia J; Bagué S; Mayodormo-Aranda E; Alvarez R; Valverde C; Martinez-Trufero J; Castilla-Ramirez C; Gutierrez A; Dopazo J; Hindi N; Garcia-Foncillas J; Martin-Broto J
    Cell Mol Life Sci; 2024 May; 81(1):219. PubMed ID: 38758230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome.
    Li M; Zhao H; Zhao SG; Wei DM; Zhao YR; Huang T; Muhammad T; Yan L; Gao F; Li L; Lu G; Chan WY; Leung PCK; Dunaif A; Liu HB; Chen ZJ
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1049-1059. PubMed ID: 30247605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic expression of the RNA binding protein IMP2 stabilizes miRNA targets in murine microsteatosis.
    Dehghani Amirabad A; Ramasamy P; Wierz M; Nordström K; Kessler SM; Schulz MH; Simon M
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3099-3108. PubMed ID: 29859241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
    Ellis BC; Graham LD; Molloy PL
    Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.
    Wu H; Ding X; Hu X; Zhao Q; Chen Q; Sun T; Li Y; Guo H; Li M; Gao Z; Yao W; Zhao L; Li K; Wei M
    Oncogene; 2022 Mar; 41(13):1959-1973. PubMed ID: 35173309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.